CoChat

Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies

Open access
Lee, Eun Ji, Choi, Yoori, Lee, Hong J., Hwang, Do Won, Lee, Dong Soo · 2022 · Journal of Nanobiotechnology

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background: Neural stem cells (NSCs) have the ability to generate a variety of functional neural cell types and have a high potential for neuronal cell regeneration and recovery. Thus, they been recognized as the best source of cell therapy for neurodegenerative diseases, such as Parkinson’s disease (PD). Owing to the possibility of paracrine effect-based therapeutic mechanisms and easier clinical accessibility, extracellular vesicles (EVs), which possess very similar bio-functional components from their cellular origin, have emerged as potential alternatives in regenerative medicine. Material and methods: EVs were isolated from human fibroblast (HFF) and human NSC (F3 cells). The supernatant of the cells was concentrated by a tangential flow filtration (TFF) system. Then, the final EVs were isolated using a total EV isolation kit. Results: In this study, we demonstrate the potential protective effect of human NSC-derived EVs, showing the prevention of PD pathologies in 6-hydroxydopamine (6-OHDA)-induced in vitro and in vivo mouse models. Human NSC and F3 cell (F3)-derived EVs reduced the intracellular reactive oxygen species (ROS) and associated apoptotic pathways. In addition, F3-derived EVs induced downregulation of pro-inflammatory factors and significantly decreased 6-OHDA-induced dopaminergic neuronal loss in vivo. F3 specific microRNAs (miRNAs) such as hsa-mir-182-5p, hsa-mir-183-5p, hsa-mir-9, and hsa-let-7, which are involved in cell differentiation, neurotrophic function, and immune modulation, were found in F3-derived EVs. Conclusions: We report that human NSC-derived EVs show an effective neuroprotective property in an in vitro transwell system and in a PD model. The EVs clearly decreased ROS and pro-inflammatory cytokines. Taken together, these results indicate that NSC-derived EVs could potentially help prevent the neuropathology and progression of PD. Graphical Abstract:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12951-022-01356-2

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Antioxidant effect of F3-derived EVs on 6-OHDA-induced oxidative stress in SH-SY5Y cells. SH-SY5Y (human neuroblastoma cell lines used as a model of dopaminergic neurons) exposed to 6-OHDA (450 µM) were treated with HFF-derived EVs (10 or 25 µg) or F3-derived EVs (10 or 25 µg). A Cell viability was measured using the CCK-8 assay 24 h after EV treatment. 6-OHDA-induced SH-SY5Y cell death was significantly reduced by treatment with F3-derived EVs. B Cellular ROS levels were measured using DCFDA. F3-derived EVs significantly reduced 6-OHDA-induced oxidative stress in SH-SY5Y cells. C Caspase 3/7 activity was measured using a luminescence assay. Caspase 3/7 activity was reduced in 6-OHDA-induced SH-SY5Y cells treated with F3-derived EVs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way ANOVA)
Fig. 1 Antioxidant effect of F3-derived EVs on 6-OHDA-induced oxidative stress in SH-SY5Y cells. SH-SY5Y (human neuroblastoma cell lines used as a model of dopaminergic neurons) exposed to 6-OHDA (450 µM) were treated with HFF-derived EVs (10 or 25 µg) or F3-derived EVs (10 or 25 µg). A Cell viability was measured using the CCK-8 assay 24 h after EV treatment. 6-OHDA-induced SH-SY5Y cell death was significantly reduced by treatment with F3-derived EVs. B Cellular ROS levels were measured using DCFDA. F3-derived EVs significantly reduced 6-OHDA-induced oxidative stress in SH-SY5Y cells. C Caspase 3/7 activity was measured using a luminescence assay. Caspase 3/7 activity was reduced in 6-OHDA-induced SH-SY5Y cells treated with F3-derived EVs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way ANOVA)CC BY · PubMed Central
Fig. 2 Anti-inflammatory effect of F3-derived EVs on LPS-treated BV2 cells and 6-OHDA-treated SH-SY5Y cells. A A heatmap of cytokine and chemokine levels in each group was shown. The changed levels were indicated in colors (yellow-increased, Purple-decreased). (Group: DPBS, LPS 0.01 µg/mL treated, 25 µg of HFF-EV treated with LPS, 25 µg of F3-EV treated with LPS). B Five significantly decreased integrated intensity of each cytokine and chemokines in the F3 EV + LPS group compared to LPS and HFF EV + LPS groups were identified. C Schematic illustration of the experimental design to validate the change of pro-inflammatory cytokine in BV2 (microglia cell line) co-cultured with 6-OHDA-treated SH-SY5Y cells using the transwell system. D, E After 24 h of treatment with F3-derived EVs to BV2 (bottom well), the expression of IL-1α and IL-1β of BV2 cells were measured using qPCR. Intracellular IL-1α and IL-1β levels were increased in BV2 cells cultured with 6-OHDA-treated SH-SY5Y cells in transwell, but the expression of these cytokines was not increased by F3-derived EVs
Fig. 2 Anti-inflammatory effect of F3-derived EVs on LPS-treated BV2 cells and 6-OHDA-treated SH-SY5Y cells. A A heatmap of cytokine and chemokine levels in each group was shown. The changed levels were indicated in colors (yellow-increased, Purple-decreased). (Group: DPBS, LPS 0.01 µg/mL treated, 25 µg of HFF-EV treated with LPS, 25 µg of F3-EV treated with LPS). B Five significantly decreased integrated intensity of each cytokine and chemokines in the F3 EV + LPS group compared to LPS and HFF EV + LPS groups were identified. C Schematic illustration of the experimental design to validate the change of pro-inflammatory cytokine in BV2 (microglia cell line) co-cultured with 6-OHDA-treated SH-SY5Y cells using the transwell system. D, E After 24 h of treatment with F3-derived EVs to BV2 (bottom well), the expression of IL-1α and IL-1β of BV2 cells were measured using qPCR. Intracellular IL-1α and IL-1β levels were increased in BV2 cells cultured with 6-OHDA-treated SH-SY5Y cells in transwell, but the expression of these cytokines was not increased by F3-derived EVsCC BY · PubMed Central
Fig. 3 MiRNA expression profiles in F3- or HFF-derived EVs by small RNA sequencing. A Heatmap showing the differences in the miRNA expression profiles in F3- and HFF-derived EVs (total 92 miRNA). Red signal indicates high expression, and blue signal indicates low expression (normalized log2 values of 8 or more and two-fold change). B Summary diagram of miRNA differentially expressed in F3-derived EVs compared to HFF-derived EVs. C Venn diagram of the number of miRNAs expressed in EVs derived from F3 and HFF cells. The top 10 miRNAs uniquely expressed in F3-derived EVs compared to HFF-derived EVs were listed. D Pie chart of the percentages of involved miRNAs based on significantly changed gene categories. E Bar graph represents the number of miRNAs with significantly increased or decreased expression within the gene categories. F Scatter plot of the comparison of miRNA expression in EVs derived from F3 and HFF cells. Red dots indicate high expression, and green dots indicate low expression. G, H Expression plots of normalized log2 data were displayed in neurogenesis and cell differentiation categories, and in immune and inflammatory response categories. I Expression of selected miRNAs (hsa-mir-20a, hsa-mir-17, hsa-mir183-5p) significantly changed between F3- and HFF-derived EVs was validated using qPCR. (J) GO analysis was conducted for target genes (mRNAs) regulated by top three miRNAs (hsa-mir-20a-5p, hsa-mir-183-5p, hsa-mir-17-5p) that were differentially expressed between F3- and HFF-derived EVs. The GO terms were listed based on p-values (p < 0.05)
Fig. 3 MiRNA expression profiles in F3- or HFF-derived EVs by small RNA sequencing. A Heatmap showing the differences in the miRNA expression profiles in F3- and HFF-derived EVs (total 92 miRNA). Red signal indicates high expression, and blue signal indicates low expression (normalized log2 values of 8 or more and two-fold change). B Summary diagram of miRNA differentially expressed in F3-derived EVs compared to HFF-derived EVs. C Venn diagram of the number of miRNAs expressed in EVs derived from F3 and HFF cells. The top 10 miRNAs uniquely expressed in F3-derived EVs compared to HFF-derived EVs were listed. D Pie chart of the percentages of involved miRNAs based on significantly changed gene categories. E Bar graph represents the number of miRNAs with significantly increased or decreased expression within the gene categories. F Scatter plot of the comparison of miRNA expression in EVs derived from F3 and HFF cells. Red dots indicate high expression, and green dots indicate low expression. G, H Expression plots of normalized log2 data were displayed in neurogenesis and cell differentiation categories, and in immune and inflammatory response categories. I Expression of selected miRNAs (hsa-mir-20a, hsa-mir-17, hsa-mir183-5p) significantly changed between F3- and HFF-derived EVs was validated using qPCR. (J) GO analysis was conducted for target genes (mRNAs) regulated by top three miRNAs (hsa-mir-20a-5p, hsa-mir-183-5p, hsa-mir-17-5p) that were differentially expressed between F3- and HFF-derived EVs. The GO terms were listed based on p-values (p < 0.05)CC BY · PubMed Central
Fig. 4 In vitro tracing of EVs secreted from palm-tdTomato virus-transduced F3 cell line in microfluidic device. A Schematic diagram of palm-tdTomato lentiviral vector for EV labeling. B TdTomato fluorescence positive F3 cells were sorted by flow cytometry after infection of palm-tdTomato lentivirus. The number of fluorescence positive cells were increased from 40 to 99%. C Confocal fluorescence images in cell-sorted tdTomato fluorescence positive F3 cells. Scale bar = 20 µm. D Schematic diagram of the two-channel microfluidic device. E F3-palm-tdTomato cells in donor channel and SH-SY5Y cells in recipient channel were co-cultured on a microfluidic device. Time-lapse imaging was used to track the migration of tdTomato fluorescence positive EVs in interchannel area (arrows) using time-lapse imaging. The imaging was performed for 6 times with 5 min intervals. F Each channel was monitored, showing tdTomato positive EVs (arrows) budding out from donor channel and migrating to the recipient channel using confocal microscopy. Scale bar = 100 µm
Fig. 4 In vitro tracing of EVs secreted from palm-tdTomato virus-transduced F3 cell line in microfluidic device. A Schematic diagram of palm-tdTomato lentiviral vector for EV labeling. B TdTomato fluorescence positive F3 cells were sorted by flow cytometry after infection of palm-tdTomato lentivirus. The number of fluorescence positive cells were increased from 40 to 99%. C Confocal fluorescence images in cell-sorted tdTomato fluorescence positive F3 cells. Scale bar = 20 µm. D Schematic diagram of the two-channel microfluidic device. E F3-palm-tdTomato cells in donor channel and SH-SY5Y cells in recipient channel were co-cultured on a microfluidic device. Time-lapse imaging was used to track the migration of tdTomato fluorescence positive EVs in interchannel area (arrows) using time-lapse imaging. The imaging was performed for 6 times with 5 min intervals. F Each channel was monitored, showing tdTomato positive EVs (arrows) budding out from donor channel and migrating to the recipient channel using confocal microscopy. Scale bar = 100 µmCC BY · PubMed Central
Fig. 5 Anti-inflammatory effect of F3-derived EVs in 6-OHDA induced PD mouse model. 6-OHDA (3 mg/mL) was intracerebrally injected with F3- or HFF-derived EVs into the left side of the SN region of the brain. A F3- and HFF-palm-tdTomato-derived EVs (arrows) were observed 24 h after injection of EVs into the SN region of the brain in PD. B, C Reactive astrocytes were identified by GFAP staining in the SN and striatum. The total area of GFAP-positive fluorescence was quantified. D, E Reactive microglia were observed by Iba1 staining in the SN and striatum in a PD mouse model. The total area of the Iba1-positive fluorescence was quantified. F, G RNA expression levels of IL-1α and IL-1β in SN tissues were obtained by qPCR analysis. 6-OHDA-induced reactive glial cells and intracellular inflammatory cytokine levels were reduced by F3-derived EV treatment Scale bar = 50 µm
Fig. 5 Anti-inflammatory effect of F3-derived EVs in 6-OHDA induced PD mouse model. 6-OHDA (3 mg/mL) was intracerebrally injected with F3- or HFF-derived EVs into the left side of the SN region of the brain. A F3- and HFF-palm-tdTomato-derived EVs (arrows) were observed 24 h after injection of EVs into the SN region of the brain in PD. B, C Reactive astrocytes were identified by GFAP staining in the SN and striatum. The total area of GFAP-positive fluorescence was quantified. D, E Reactive microglia were observed by Iba1 staining in the SN and striatum in a PD mouse model. The total area of the Iba1-positive fluorescence was quantified. F, G RNA expression levels of IL-1α and IL-1β in SN tissues were obtained by qPCR analysis. 6-OHDA-induced reactive glial cells and intracellular inflammatory cytokine levels were reduced by F3-derived EV treatment Scale bar = 50 µmCC BY · PubMed Central
Fig. 6 Protective effect of F3-derived EVs on dopaminergic cell viability in 6-OHDA- induced PD mouse model. A Immunofluorescence staining of TH was performed to detect viability of TH-positive dopaminergic neurons in SN. The red box indicates ipsilateral regions. scale bar = 1 mm. B Magnified images of the ipsilateral and contralateral sides of the SN were shown. Degeneration of TH-positive dopaminergic neurons by 6-OHDA was attenuated by F3-derived EVs treatment in SN. N = 3, scale bar = 50 µm. C Schematic diagram for the protective effect of F3-derived EVs against 6-OHDA was shown. Anti-oxidative stress and anti-inflammatory effects of EVs containing miRNAs that are involved in dopaminergic neuronal protection were displayed. NSC neural stem cell. SN substantia nigra, EV extracellular vesicles, ROS reactive oxygen species
Fig. 6 Protective effect of F3-derived EVs on dopaminergic cell viability in 6-OHDA- induced PD mouse model. A Immunofluorescence staining of TH was performed to detect viability of TH-positive dopaminergic neurons in SN. The red box indicates ipsilateral regions. scale bar = 1 mm. B Magnified images of the ipsilateral and contralateral sides of the SN were shown. Degeneration of TH-positive dopaminergic neurons by 6-OHDA was attenuated by F3-derived EVs treatment in SN. N = 3, scale bar = 50 µm. C Schematic diagram for the protective effect of F3-derived EVs against 6-OHDA was shown. Anti-oxidative stress and anti-inflammatory effects of EVs containing miRNAs that are involved in dopaminergic neuronal protection were displayed. NSC neural stem cell. SN substantia nigra, EV extracellular vesicles, ROS reactive oxygen speciesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Yuan P, Ding L, Chen H, Wang Y, Li C, Zhao S, et al. Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis. Front Cell Dev Biol. 2021;9:601600. · DOI · Paper page

Cited by

See all 89

Metadata

Authors
Lee, E. J., Choi, Y., Lee, H. J., Hwang, D. W., & Lee, D. S.
Affiliations
  • Seoul National University (KR)
  • Chungbuk National University (KR)
Corresponding author
  • Hwang, Do Won
  • Lee, Dong Soo
Venue
Journal of Nanobiotechnology
Published
2022-04-25
Volume
20
Issue
1
Pages
198-198
ISSN
1477-3155 (ISSN-L)
OpenAlex
W4224322616
Cited by
89
References
38
Citations by year
2026: 20 · 2025: 25 · 2024: 21 · 2023: 16 · 2022: 7
FWCI
5.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Nanobiotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders
  • National Research Foundation of Korea (NRF-2020 R1A2C2101069, 2017M3C7A1048079)
  • Korea National Institute of Health (HI14C1277)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
Parkinson's disease, neural stem cells, extracellular vesicles, neuroprotection, 6-hydroxydopamine, dopaminergic neuron loss, reactive oxygen species, apoptosis, neuroinflammation, microRNA, cell therapy, paracrine signaling
MeSH terms
Extracellular Vesicles, Animals, Humans, Parkinson Disease, Oxidopamine, Reactive Oxygen Species, MicroRNAs, Mice, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. https://app.cochat.ai/papers/10.1186/s12951-022-01356-2
The paper
Lee, E. J., Choi, Y., Lee, H. J., Hwang, D. W., & Lee, D. S. (2022). Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-022-01356-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.